Comparative Pharmacology
Head-to-head clinical analysis: CHLORHEXIDINE GLUCONATE versus CHLOROFAIR.
Peer-Reviewed Evidence
Head-to-head clinical analysis: CHLORHEXIDINE GLUCONATE versus CHLOROFAIR.
CHLORHEXIDINE GLUCONATE vs CHLOROFAIR
Comparing the clinical profiles, pharmacokinetic behaviors, and safety indices of these two therapeutic agents.
Cationic bisbiguanide that disrupts microbial cell membranes by binding to negatively charged cell wall components, increasing permeability and causing leakage of cytoplasmic contents; also inhibits bacterial enzymes and precipitates cytoplasmic constituents.
Chloramphenicol inhibits bacterial protein synthesis by binding to the 50S ribosomal subunit, preventing peptide bond formation.
Oral rinse: 15 mL of 0.12% solution swished in mouth for 30 seconds twice daily; topical: apply 2% cream or lotion to affected area 2-3 times daily.
125 mg IV every 6 hours for 10 days.
None Documented
None Documented
Terminal half-life approximately 12-24 hours; may be prolonged in hepatic impairment.
4.5 hours (prolonged to 10–12 hours in renal impairment)
Primarily renal (10-30% unchanged) and biliary/fecal (majority as metabolites).
Renal: 70% unchanged; hepatic metabolism: 25% conjugated; fecal: 5%
Category C
Category C
Antiseptic
Antiseptic